Special populations: drug interactions Flashcards
1
Q
List the different populations that may require special consideration when prescribing.
A
- Drug companies design PIII studies to be successful. Therefore, often does not reflect the real-world patient.
- Groups:
1. Children
2. Women
3. Pregnant women
4. Elderly
5. Ethnic groups
6. Patients with other diseases – Patients on other medications
2
Q
How these populations can differ in their response to drugs.
A
- Responses differ because:
1. Different pharmacokinetics
2. Different rates of clearance
3. Different metabolism
4. Different pharmacodynamics
3
Q
Discuss the difference in response to drugs in elderly people.
A
- Changes in body composition e.g. reduced lean mass, ^ fat content.
- Changes in clearance: decreased renal function
- Changes in metabolism: Decreased hepatic blood flow and liver mass. Decreased cytP450 levels
4
Q
Describe the effect of liver disease on prescribing
A
- In the elderly: Changes in metabolism of the drug due to decreased hepatic blood flow and liver mass. Decreased cytP450 levels but not in conjugation enzymes.
- Results in:
1. Increased sensitivity to CNS depressants
2. Increased sensitivity to adverse effects
3. Often due to impaired compensatory mechanisms.
5
Q
Describe the effect of kidney disease on prescribing
A
- In the elderly: changes in clearance due to decreased renal function.
- Results in elimination half-life being increased.
- Increased volume of distribution of lipid-soluble drugs.
6
Q
Describe the basis of drug-drug interactions?
A
- Occurs when one drug alters the concentration of another drug with clinical consequences.
- 3 types:
1. Duplication: 2 drugs with the same effect are taken, side effects ^.
2. Opposition (antagonism): 2 drugs with opposing actions can interact, thereby reducing the effectiveness of one or both.
3. Alteration: 1 drug may alter how the body absorbs, distributes, metabolises, or excretes another drug.